Maase FY2026 20-F: RMB183M Revenue, RMB1.84B Discontinued-Ops Loss, US$13.5M Arbitration Security
MAAS has more than doubled off its 52-week low of $3.5.
Summary
Maase's FY2026 annual report shows RMB183.4 million of revenue from its new AI, EV-charging and wellness businesses, but a RMB1.84 billion loss from discontinued operations and a balance sheet concentrated in ginseng/tea inventory and goodwill. The company also disclosed a US$13.5 million arbitration security order due by November 2026.
Key Events · Earnings and Guidance · MAAS
-
First Full-Year Results After Transformation
FY2026 continuing operations revenue was RMB183.4 million (US$27.0 million) versus nil in FY2025, led by computing power and algorithm solutions at RMB153.7 million, or 83.8% of the total.
-
RMB1.84 Billion Discontinued-Operations Loss
Net loss from discontinued operations was RMB1.84 billion (US$271.0 million), driven largely by a RMB1.69 billion 'Others, net' charge within the deconsolidated AIFU Group; net loss attributable to owners was RMB187.2 million (US$27.6 million).
-
Balance Sheet Concentrated in Inventory and Goodwill
Inventories of RMB2.41 billion (US$355.1 million) are about 49% of total assets, mostly wild ginseng and high-grade tea held as long-term reserves; goodwill of RMB2.02 billion (US$297.4 million) is about 43% of total assets, with no impairment taken in FY2026.
-
US$13.5 Million Arbitration Security Due November 2026
The sole arbitrator in the GEM Global Yield arbitration directed Maase to post US$13.5 million of partial security by November 2026; the evidential hearing is scheduled for March 2027 and no loss provision has been accrued.
Analysis · MAAS · Finance
Here is the first full-year look at Maase after it sold or deconsolidated its entire legacy financial-services business and bought its way into AI computing, EV charging and health products. Continuing operations generated RMB183.4 million of revenue against nil a year earlier, but exiting the old businesses cost RMB1.84 billion in discontinued-operations losses, driving a RMB187.2 million net loss attributable to owners. Ginseng and tea inventory of RMB2.41 billion (about 49% of total assets) and goodwill of RMB2.02 billion (about 43%) now dominate the balance sheet, and their value hinges on commercialization plans management says are not near-term. With only RMB37.1 million of cash and negative RMB103.4 million operating cash flow, the company is leaning on the US$50 million PIPE at US$12.89 per share and a US$500 million shelf. Separately, the arbitrator in the GEM dispute has ordered US$13.5 million of partial security by November 2026, with the evidential hearing set for March 2027.
How filings like this one have moved
In the 30 days to Oct 26, 2026, 36.2% of the 898 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.75%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MAAS was trading at $12.00 on NASDAQ in the Finance sector, with a market capitalization of approximately $5.3B. The 52-week trading range was $3.50 to $24.90. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.